Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

A randomized controlled trial of misoprostol monotherapy for canine atopic dermatitis: effects on dermal cellularity and cutaneous tumour necrosis factor-alpha.

Olivry T, Dunston SM, Rivierre C, Jackson HA, Murphy KM, Peters E, Dean GA.

Vet Dermatol. 2003 Feb;14(1):37-46.

PMID:
12603684
2.

Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial.

Olivry T, Rivierre C, Jackson HA, Murphy KM, Davidson G, Sousa CA.

Vet Dermatol. 2002 Apr;13(2):77-87.

PMID:
11972891
3.

Single blinded, randomized, placebo-controlled study on the effects of ciclosporin on cutaneous barrier function and immunological response in atopic beagles.

White AG, Santoro D, Ahrens K, Marsella R.

Vet Immunol Immunopathol. 2018 Mar;197:93-101. doi: 10.1016/j.vetimm.2018.02.001. Epub 2018 Feb 7.

PMID:
29475513
4.

Randomized controlled trial of the efficacy of cyclosporine in the treatment of atopic dermatitis in dogs.

Olivry T, Steffan J, Fisch RD, Prélaud P, Guaguère E, Fontaine J, Carlotti DN; European Veterinary Dermatology Cyclosporine Group.

J Am Vet Med Assoc. 2002 Aug 1;221(3):370-7.

PMID:
12164533
5.

Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo-controlled trial.

Nuttall T, Mueller R, Bensignor E, Verde M, Noli C, Schmidt V, Rème C.

Vet Dermatol. 2009 Jun;20(3):191-8. doi: 10.1111/j.1365-3164.2009.00756.x. Epub 2009 Apr 3.

PMID:
19374721
6.

A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis.

Cosgrove SB, Wren JA, Cleaver DM, Walsh KF, Follis SI, King VI, Tena JK, Stegemann MR.

Vet Dermatol. 2013 Dec;24(6):587-97, e141-2. doi: 10.1111/vde.12088.

7.

A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.

Little PR, King VL, Davis KR, Cosgrove SB, Stegemann MR.

Vet Dermatol. 2015 Feb;26(1):23-30, e7-8. doi: 10.1111/vde.12186. Epub 2014 Dec 12.

8.
9.

Pilot evaluation of the antipruritic efficacy of a topical transient receptor potential melastatin subfamily 8 (TRPM8) agonist in dogs with atopic dermatitis and pedal pruritus.

Tamamoto-Mochizuki C, Murphy KM, Olivry T.

Vet Dermatol. 2018 Feb;29(1):29-e14. doi: 10.1111/vde.12486. Epub 2017 Sep 26.

PMID:
28952176
11.
12.
13.

Management of canine atopic dermatitis using the plant extract PYM00217: a randomized, double-blind, placebo-controlled clinical study.

Ferguson EA, Littlewood JD, Carlotti DN, Grover R, Nuttall T.

Vet Dermatol. 2006 Aug;17(4):236-43.

PMID:
16827666
14.
15.

Clinical trial evaluating the efficacy and safety of cyclosporine in dogs with atopic dermatitis.

Steffan J, Parks C, Seewald W; North American Veterinary Dermatology Cyclosporine Study Group.

J Am Vet Med Assoc. 2005 Jun 1;226(11):1855-63.

PMID:
15934253
16.

Evaluation of cyclosporine-sparing effects of polyunsaturated fatty acids in the treatment of canine atopic dermatitis.

Müller MR, Linek M, Löwenstein C, Röthig A, Doucette K, Thorstensen K, Mueller RS.

Vet J. 2016 Apr;210:77-81. doi: 10.1016/j.tvjl.2015.11.012. Epub 2015 Dec 1.

PMID:
26975448
17.

Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis.

Nuttall TJ, McEwan NA, Bensignor E, Cornegliani L, Löwenstein C, Rème CA.

Vet Dermatol. 2012 Feb;23(1):4-10, e1-2. doi: 10.1111/j.1365-3164.2011.00992.x. Epub 2011 Jul 1.

PMID:
21718368
18.

A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis.

Michels GM, Ramsey DS, Walsh KF, Martinon OM, Mahabir SP, Hoevers JD, Walters RR, Dunham SA.

Vet Dermatol. 2016 Dec;27(6):478-e129. doi: 10.1111/vde.12376. Epub 2016 Sep 19.

PMID:
27647569
19.

Barazone decreases skin lesions and pruritus and increases quality of life in dogs with atopic dermatitis: a randomized, blinded, placebo-controlled trial.

Ahlstrom LA, Mason KV, Mills PC.

J Vet Pharmacol Ther. 2010 Dec;33(6):573-82. doi: 10.1111/j.1365-2885.2010.01181.x.

PMID:
21062310
20.

Supplemental Content

Support Center